Shafer S L, Varvel J R, Gronert G A
Department of Anesthesia, Stanford University Medical Center, California.
J Pharmacokinet Biopharm. 1989 Jun;17(3):291-304. doi: 10.1007/BF01061898.
We investigated the ability of two pharmacokinetic modeling techniques to estimate the equilibration delay (i.e., hysteresis) between plasma drug concentration and observed drug effect. The data were from 20 animals (15 dogs, 5 pigs) receiving an infusion of metocurine, a neuromuscular blocking drug. An effect compartment model was used to model the hysteresis and characterize the relationship between drug concentration and effect. The effect compartment model requires identification of ke0, the rate constant of drug elimination from the effect compartment. Two methods were used to estimate ke0. The first technique was to fit the plasma metocurine concentration-time curve to a two-compartment pharmacokinetic model and then to use this pharmacokinetic model, along with the neuromuscular blockade vs. time curve to estimate ke0 and the parameters of a pharmacodynamic model (the Hill equation). The second technique was to directly estimate ke0 by a recently described semiparametric technique that does not require either a pharmacokinetic or pharmacodynamic model, although it does assume that drug flux to and from the effect compartment is a first-order process. This semiparametric technique only estimates a single parameter, ke0. The results from the new semiparametric analysis technique were similar to the results from the parametric analysis. In the few animals where the results differed, the semiparametric analysis produced a better description of the data.
我们研究了两种药代动力学建模技术估算血浆药物浓度与观察到的药物效应之间平衡延迟(即滞后现象)的能力。数据来自20只接受米库氯铵(一种神经肌肉阻滞药物)输注的动物(15只狗,5只猪)。采用效应室模型对滞后现象进行建模,并描述药物浓度与效应之间的关系。效应室模型需要确定ke0,即药物从效应室消除的速率常数。使用两种方法估算ke0。第一种技术是将血浆米库氯铵浓度-时间曲线拟合为二室药代动力学模型,然后使用该药代动力学模型以及神经肌肉阻滞与时间曲线来估算ke0和药效学模型(希尔方程)的参数。第二种技术是通过最近描述的半参数技术直接估算ke0,该技术不需要药代动力学或药效学模型,不过它确实假定进出效应室的药物通量是一级过程。这种半参数技术仅估算单个参数ke0。新的半参数分析技术的结果与参数分析的结果相似。在少数结果不同的动物中,半参数分析对数据的描述更好。